Cyclin D1 and prognosis in human breast cancer.

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res (2009) 5.20

The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer (2007) 3.28

Tailoring to RB: tumour suppressor status and therapeutic response. Nat Rev Cancer (2008) 3.16

Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev (1998) 1.97

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A (1997) 1.81

Transcriptional regulation of the cyclin D1 gene at a glance. J Cell Sci (2008) 1.81

Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Res (2006) 1.68

ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells. Mol Cell Biol (2002) 1.55

Targeting the RB-pathway in cancer therapy. Clin Cancer Res (2010) 1.54

Cyclin D1 and human neoplasia. Mol Pathol (1998) 1.50

leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem (2007) 1.48

Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer. Clin Cancer Res (2009) 1.43

Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment. Br J Cancer (2002) 1.43

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Br J Cancer (2004) 1.36

Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function. J Cell Biol (2001) 1.19

Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol (2000) 1.16

Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer. Breast Cancer Res (2008) 1.15

Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome. Oncogene (2009) 1.15

Cyclin D1, Id1 and EMT in breast cancer. BMC Cancer (2011) 1.13

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance. Clin Med Insights Oncol (2010) 1.13

Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors. Breast Cancer Res (2013) 1.08

CDK4: A Key Player in the Cell Cycle, Development, and Cancer. Genes Cancer (2012) 1.07

Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays. Br J Cancer (2002) 1.06

Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3. Carcinogenesis (2010) 1.04

Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study. Breast Cancer Res (2012) 1.03

MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer. Expert Rev Mol Diagn (2009) 1.02

Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features. Am J Pathol (2010) 1.02

MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. PLoS One (2013) 1.02

Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer (2003) 1.00

Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence. Br J Cancer (2003) 1.00

Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer (1999) 0.97

Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions. Breast Cancer Res (2014) 0.96

Immunohistochemical expression of cyclin D1 in ameloblastomas and adenomatoid odontogenic tumors. J Oral Maxillofac Pathol (2011) 0.96

Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling. Oncogene (2010) 0.93

Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells. Br J Cancer (1999) 0.91

Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity. Cell Cycle (2013) 0.89

Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells. BMC Complement Altern Med (2011) 0.89

Protein signatures for classification and prognosis of gastric cancer a signaling pathway-based approach. Am J Pathol (2011) 0.89

Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer. BMC Res Notes (2012) 0.88

G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder. Br J Cancer (1999) 0.88

Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients. Br J Cancer (1997) 0.87

Cyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma. ScientificWorldJournal (2012) 0.86

Prognosis of treatment response (pathological complete response) in breast cancer. Biomark Insights (2012) 0.86

Polydatin inhibits growth of lung cancer cells by inducing apoptosis and causing cell cycle arrest. Oncol Lett (2013) 0.86

The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma. Br J Cancer (2000) 0.85

Genetically engineered mice as experimental tools to dissect the critical events in breast cancer. Adv Cancer Res (2014) 0.84

Regulation of glioblastoma progression by cord blood stem cells is mediated by downregulation of cyclin D1. PLoS One (2011) 0.84

Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells. PLoS One (2013) 0.82

KiSS1/GPR54 and estrogen-related gene expression profiles in primary breast cancer. Oncol Lett (2012) 0.81

The pathology of hereditary breast cancer. Hered Cancer Clin Pract (2004) 0.81

Cyclin D1 expression in prostate carcinoma. Braz J Med Biol Res (2014) 0.81

Lack of cyclin E immunoreactivity in non-malignant breast and association with proliferation in breast cancer. Br J Cancer (1997) 0.81

P53 expression is significantly correlated with high risk of malignancy and epithelioid differentiation in GISTs. An immunohistochemical study of 104 cases. BMC Cancer (2008) 0.80

Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry. Br J Cancer (1998) 0.80

Expression of cell cycle proteins in male breast carcinoma. World J Surg Oncol (2010) 0.80

D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance. J Cancer Res Clin Oncol (2010) 0.79

Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer. Mol Pathol (1998) 0.78

Neuregulin 1-Beta cytoprotective role in AML 12 mouse hepatocytes exposed to pentachlorophenol. Int J Environ Res Public Health (2006) 0.78

SUMOylation of RhoGDIα is required for its repression of cyclin D1 expression and anchorage-independent growth of cancer cells. Mol Oncol (2013) 0.78

The Discodermia calyx toxin calyculin a enhances cyclin D1 phosphorylation and degradation, and arrests cell cycle progression in human breast cancer cells. Toxins (Basel) (2011) 0.78

Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progression. Mol Med (1997) 0.78

Cyclin D1 expression does not effect cell proliferation in adenoid cystic carcinoma of the salivary gland. Eur Arch Otorhinolaryngol (2004) 0.78

Protein expression patterns of cell cycle regulators in operable breast cancer. PLoS One (2017) 0.77

No difference in CCND1 gene expression between breast cancer patients with and without lymph node metastasis in a Southern Brazilian sample. Clin Exp Med (2015) 0.76

Impaired nuclear export of tumor-derived c-terminal truncated cyclin D1 mutant in ESCC cancer. Oncol Lett (2011) 0.75

Positive expression of cyclin D1 is an indicator for the evaluation of the prognosis of breast cancer. Int J Clin Exp Med (2015) 0.75

Cyclin d1 gene expression in oral mucosa of tobacco chewers"-an immunohistochemical study. J Clin Diagn Res (2014) 0.75

Role of traditional and new biomarkers in breast carcinogenesis. Ecancermedicalscience (2009) 0.75

Association among the expression of β-catenin, cyclin D1 and estrogen receptor-β in human breast cancer. Exp Ther Med (2015) 0.75

High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers. Breast Cancer Res Treat (2017) 0.75

Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med (2001) 14.84

A self-report measure of pubertal status: Reliability, validity, and initial norms. J Youth Adolesc (1988) 12.12

FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J Virol (1982) 6.11

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J (1998) 6.08

Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol (1997) 5.47

Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis (1982) 5.40

Phytochrome and Seed Germination. I. Temperature Dependence and Relative P(FR) Levels in the Germination of Dark-germinating Tomato Seeds. Plant Physiol (1967) 5.14

Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03

A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med (2001) 4.87

Equity of access to health care services: theory and evidence from the UK. Soc Sci Med (2001) 4.83

Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost (2000) 4.81

The emerging tree of West Eurasian mtDNAs: a synthesis of control-region sequences and RFLPs. Am J Hum Genet (1999) 4.80

p14ARF links the tumour suppressors RB and p53. Nature (1998) 4.78

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (1995) 4.78

Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol (1996) 4.67

Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol (2000) 4.58

The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta (1998) 4.45

Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J Virol (1987) 4.37

Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med (2001) 4.19

Attempt at deriving a formula for setting general practitioner fundholding budgets. BMJ (1994) 4.19

Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature (2001) 4.14

Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus. EMBO J (1986) 4.08

The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer (2004) 4.06

Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res (1996) 3.89

Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Cell (1983) 3.89

Allocating resources to health authorities: development of method for small area analysis of use of inpatient services. BMJ (1994) 3.88

The life course prospective design: an example of benefits and problems associated with study longevity. Soc Sci Med (2003) 3.84

A transformation of self-discrimination response functions in accordance with the arbitrarily applicable relations of sameness, more than, and less than. J Exp Anal Behav (1995) 3.70

Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res (1994) 3.65

Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis (1998) 3.61

Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell (1984) 3.61

Microbial colonization of prosthetic devices. II. Scanning electron microscopy of naturally infected intravenous catheters. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 3.53

Mitochondrial footprints of human expansions in Africa. Am J Hum Genet (1997) 3.42

Serum-free cell culture: a unifying approach. Cell (1980) 3.41

Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets. Br J Cancer (2012) 3.37

Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis (1992) 3.30

A signal, from human mtDNA, of postglacial recolonization in Europe. Am J Hum Genet (2001) 3.28

Methods for growth of cultured cells in serum-free medium. Anal Biochem (1980) 3.27

A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol (1997) 3.25

Agriculture. Sustainable intensification in agriculture: premises and policies. Science (2013) 3.24

Subcellular fate of the int-2 oncoprotein is determined by choice of initiation codon. Nature (1990) 3.19

Race/ethnic differences in AD survival in US Alzheimer's Disease Centers. Neurology (2007) 3.18

Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill (2010) 3.15

Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis (1988) 3.09

Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models. Health Technol Assess (2007) 3.04

Low-molecular-weight RNAs of Moloney murine leukemia virus: identification of the primer for RNA-directed DNA synthesis. J Virol (1977) 2.99

The origins of the Polynesians: an interpretation from mitochondrial lineage analysis. Am J Hum Genet (1995) 2.98

Specific binding of tryptophan transfer RNA to avian myeloblastosis virus RNA-dependent DNA polymerase (reverse transcriptase). Proc Natl Acad Sci U S A (1975) 2.97

The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell (1999) 2.97

Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet (1994) 2.96

The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer (1999) 2.89

A transfer of functions through derived arbitrary and nonarbitrary stimulus relations. J Exp Anal Behav (1993) 2.89

Do the four clades of the mtDNA haplogroup L2 evolve at different rates? Am J Hum Genet (2001) 2.88

Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis (1997) 2.82

Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun (1986) 2.80

EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J (1994) 2.79

Intravenous cefotaxime in children with bacterial meningitis. Lancet (1980) 2.77

IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity (2000) 2.74

Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research. BMJ (1994) 2.70

Comparison of CT scan muscle measurements and isokinetic trunk strength in postoperative patients. Spine (Phila Pa 1976) (1989) 2.70

Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat Cell Biol (2001) 2.66

A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun (1997) 2.65

Rapid and specific detection of toxigenic Staphylococcus aureus: use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J Clin Microbiol (1998) 2.60

A transformation of respondently conditioned stimulus function in accordance with arbitrarily applicable relations. J Exp Anal Behav (1997) 2.56

CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene (1994) 2.55

Phytochrome and Seed Germination. III. Action of Prolonged Far Red Irradiation on the Germination of Tomato and Cucumber Seeds. Plant Physiol (1967) 2.54

Staphylococcus aureus RN6390 replicates and induces apoptosis in a pulmonary epithelial cell line. Infect Immun (2000) 2.54

Potential oncogene product related to growth factors. Nature (1987) 2.53

Molecular genetic analyses of the Tyrolean Ice Man. Science (1994) 2.53

Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer (1981) 2.53

Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest (2001) 2.49

Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med (1998) 2.49

Family history and perceived vulnerability to some common diseases: a study of young people and their parents. J Med Genet (1996) 2.49

Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. Br J Ophthalmol (1994) 2.47

The role of liver biopsy in chronic hepatitis C. Hepatology (2001) 2.47

Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol (2001) 2.45

Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol (1998) 2.42

Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med (1993) 2.42

One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Br Med J (Clin Res Ed) (1982) 2.39

Imaging protein kinase Calpha activation in cells. Science (1999) 2.37

Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet (1984) 2.35

Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain (1988) 2.29

Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer (1996) 2.28

The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. Curr Top Microbiol Immunol (2002) 2.27

Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J (1995) 2.26

ABC of palliative care. The carers. BMJ (1998) 2.25

The effect of brief halothane anesthesia during daily gavage on complications and body weight in rats. Contemp Top Lab Anim Sci (2001) 2.25

A transfer of self-discrimination response functions through equivalence relations. J Exp Anal Behav (1994) 2.24

Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus. Nature (1986) 2.24

Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet (1992) 2.22

D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene (1991) 2.21

Genetic evidence for different male and female roles during cultural transitions in the British Isles. Proc Natl Acad Sci U S A (2001) 2.20

Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer (1998) 2.20

Prevention of osteoporosis in glucocorticoid-treated neurology patients. Clin Neurol Neurosurg (2005) 2.19

European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17

Assessing patient dependence in Alzheimer's disease. J Gerontol (1994) 2.16

Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. Clin Infect Dis (2001) 2.14

Using a birth cohort to study ageing: representativeness and response rates in the National Survey of Health and Development. Eur J Ageing (2013) 2.12